title: HMG CoA reductase inhibition and endothelial function in children with chronic kidney disease (CKD)--a pilot study.
authors.affiliation: Sydney Children's Hospital Randwick, New South Wales, NSW, Australia. f.mackie@unsw.edu.au
authors.forename: Fiona E
authors.initials: FE
authors.lastname: Mackie
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Rosenberg
authors.forename: Jason A
authors.initials: JA
authors.lastname: Harmer
authors.forename: Gad
authors.initials: G
authors.lastname: Kainer
authors.forename: David S
authors.initials: DS
authors.lastname: Celermajer
mesh_terms: D000293:Adolescent; D000069059:Atorvastatin; D001794:Blood Pressure / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000503:physiopathology; D006538:Heptanoic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D008055:Lipids / Q000097:blood; D010865:Pilot Projects; D011446:Prospective Studies; D011758:Pyrroles / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D011758:Pyrroles; D000069059:Atorvastatin